Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (157)
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
79
Price
$202.42
Total Value
$15.99K
Shares Held After
42,455
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
40
Price
$201.24
Total Value
$8.05K
Shares Held After
42,534
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
146
Price
$199.97
Total Value
$29.20K
Shares Held After
42,574
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.45
Total Value
$275.42K
Shares Held After
451,540
% of Holdings
4.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
337
Price
$204.50
Total Value
$68.92K
Shares Held After
41,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
963
Price
$203.22
Total Value
$195.70K
Shares Held After
41,719
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$201.90
Total Value
$141.33K
Shares Held After
42,682
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,238
Price
$200.94
Total Value
$248.77K
Shares Held After
43,382
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,302
Price
$199.72
Total Value
$260.04K
Shares Held After
44,620
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$198.85
Total Value
$91.47K
Shares Held After
45,922
% of Holdings
1.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$20.97
Total Value
$98.20K
Shares Held After
80,351
% of Holdings
5.5%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
942
Price
$52.75
Total Value
$49.69K
Shares Held After
105,673
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,000
Price
$65.71
Total Value
$65.71K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
19,000
Price
$65.36
Total Value
$1.24M
Shares Held After
768,780
% of Holdings
2.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$48.33
Total Value
$1.59M
Shares Held After
32,916
% of Holdings
50.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
105,211
% of Holdings
8.7%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$48.33
Total Value
$90.62K
Shares Held After
42,011
% of Holdings
4.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
25,098
Price
$31.46
Total Value
$789.58K
Shares Held After
432,886
% of Holdings
5.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
34,902
Price
$30.55
Total Value
$1.07M
Shares Held After
457,984
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$596.11
Total Value
$143.07K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$595.29
Total Value
$119.06K
Shares Held After
40,753
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$594.11
Total Value
$261.41K
Shares Held After
40,953
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$592.98
Total Value
$142.32K
Shares Held After
41,393
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$591.64
Total Value
$165.66K
Shares Held After
41,633
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$590.69
Total Value
$91.56K
Shares Held After
41,913
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
469
Price
$589.66
Total Value
$276.55K
Shares Held After
42,068
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
450
Price
$588.63
Total Value
$264.88K
Shares Held After
42,537
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
846
Price
$587.60
Total Value
$497.11K
Shares Held After
42,987
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
247
Price
$586.61
Total Value
$144.89K
Shares Held After
43,833
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$585.11
Total Value
$93.62K
Shares Held After
44,080
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
31
Price
$583.56
Total Value
$18.09K
Shares Held After
44,240
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
602
Price
$582.75
Total Value
$350.82K
Shares Held After
44,271
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
610
Price
$581.72
Total Value
$354.85K
Shares Held After
44,873
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
190
Price
$580.54
Total Value
$110.30K
Shares Held After
45,483
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$579.35
Total Value
$162.22K
Shares Held After
45,673
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$578.56
Total Value
$138.86K
Shares Held After
45,953
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$577.13
Total Value
$207.77K
Shares Held After
46,193
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$576.02
Total Value
$229.83K
Shares Held After
46,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$574.87
Total Value
$276.51K
Shares Held After
46,952
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
310
Price
$573.92
Total Value
$177.92K
Shares Held After
47,433
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
931
Price
$572.81
Total Value
$533.28K
Shares Held After
47,743
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
801
Price
$571.58
Total Value
$457.84K
Shares Held After
48,674
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
538
Price
$570.87
Total Value
$307.13K
Shares Held After
49,475
% of Holdings
1.1%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,946
Price
$6.31
Total Value
$69.07K
Shares Held After
113,856
% of Holdings
8.8%
Protara Therapeutics, Inc. (TARA)
Zummo Jacqueline — Chief R&D Officer
Shares
22,598
Price
$5.26
Total Value
$118.87K
Shares Held After
95,961
% of Holdings
19.1%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
28,662
Price
$32.31
Total Value
$926.10K
Shares Held After
9,597
% of Holdings
74.9%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$9.07
Total Value
$199.62K
Shares Held After
1,100,391
% of Holdings
2.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Sabar Karimah Es — Director
Shares
53,735
Price
$31.03
Total Value
$1.67M
Shares Held After
0
% of Holdings
100.0%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$35.51
Total Value
$319.60K
Shares Held After
85,389
% of Holdings
9.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,100
Price
$86.05
Total Value
$94.66K
Shares Held After
61,202
% of Holdings
1.8%
Showing 101–150 of 157 transactions (page 3 of 4)